Rating History for Cerevel Therapeutics (CERE) by Stifel

More Stocks Rated by Stifel | Latest Ratings for CERE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/18/2023 Paul Matteis Downgrade Hold
(Buy)		 45.00
(N/A)		 41.22
(44.96)		 9.07% Details